- About us
- Corporate responsibility
- Business Development
UNI-PHARMA was founded 54 years ago by the pharmacist, Kleon Tsetis, who had a vision to strengthen the presence of Greek companies in the Pharmaceutical Industry, through the development, production and distribution of innovative drugs. This, was accomplished within the first year of the company’s operation. UNI-PHARMA has been the first company worldwide to introduce phenobarbital as an oral solution, LUMIDROPS®, as well as a combination of phenobarbital and omatropin, NOVALUMINE®.
The course of UNI-PHARMA in the pharmaceutical industry has been marked also by a numerous of other successful products, which resulted in high gratitude and support from the medical and pharmaceutical world and established the company’s reputation of producing safe, effective and quality products. Most specifically:
SALOSPIR®, which was launched in 1977, was the first acetylsalicylic acid-based product introduced in Europe in the form of enteric-coated tablets, with formulations ranging from 80 – 1.000mg.
APOTEL®, which was launched in 1992, was the world’s first injectable paracetamol drug, based on a new method for the dissolution of paracetamol, developed by UNI-PHARMA.
T4®, for the treatment of thyroid disorders, is available in 13 different concentrations, providing individualized dosage schemes.
Uni-Pharma is a pioneer company in Greece, specializing also in the manufacture of effervescent forms of acetylsalicylic acid, acetylsalicylic acid combined with vitamin C, paracetamol and a combination of paracetamol with vitamin C in aluminium foil packaging
Apart from the research in the area of pharmaceutical manufacturing, the company's scientific team has been involved in the development of new production methods for raw materials such as acyclovir, ciproﬂoxacin and famotidine for which Uni-Pharma has been granted Greek patents. In 1998, Uni-Pharma was granted an E.U. patent for injectable solutions of paracetamol and paracetamol combinations with other active substances.
Since its establishment 54 years ago, Uni-Pharma has evolved from a small, sole proprietorship/ family –owned company to a large and dynamic pharmaceutical industry that develops and produces pharmaceutical products, food supplements and medical devices, holding the first place, among Greek companies, in unit sales, and is constantly expanding its portfolio and the markets in which it operates.